Ожирение как причина сахарного диабета 2-го типа (понятие «diabesity»). Роль кишечной микробиоты в терапии сахарного диабета (реферат)
Ожирение как причина сахарного диабета 2-го типа (понятие «diabesity»). Роль кишечной микробиоты в терапии сахарного диабета (реферат). FOCUS Эндокринология. 2021; 3: 24–30. DOI: 10.47407/ef2021.2.3.0031
Type 2 Diabetes Mellitus Associated with Obesity (Diabesity). The Central Role of Gut Microbiota and Its Translational Applications (abstract). FOCUS Endocrinology. 2021; 3: 24–30. DOI: 10.47407/ef2021.2.3.0031
Публикуется реферат по статье «Type 2 Diabetes Mellitus Associated with Obesity (Diabesity). The Central Role of Gut Microbiota and Its Translational Applications». В данном материале авторы рассматривают ожирение не только с точки зрения растущей проблемы здравоохранения, социально-экономического бремени, но и как серьезный фактор риска развития сахарного диабета 2-го типа, акцентируя внимание на понятии «diabesity» (diabetes + obesity). Кроме того, изучается вопрос о роли микробиоты кишечника у пациентов с ожирением и сахарным диабетом 2-го типа.
Ключевые слова: ожирение, сахарный диабет 2-го типа, diabesity, кишечная микробиота, дисбактериоз.
Ключевые слова: ожирение, сахарный диабет 2-го типа, diabesity, кишечная микробиота, дисбактериоз.
1. World Health Organization. Obesity: preventing and managing the global epidemic. Geneva: WHO, 1997.
2. Ortega MA, Fraile-Martínez O, Naya I et al. Type 2 Diabetes Mellitus Associ-ated with Obesity (Diabesity). The Central Role of Gut Microbiota and Its Translational Applications. Nutrients 2020; 12 (9): 2749. Published 2020 Sep 9. DOI: 10.3390/nu12092749
3. World Health Organization. Fact sheets. Obesity and overweight. 09.06.2021. https://www.who.int/ru/news-room/fact-sheets/detail/obe-sity-and-overweight. [Access date: 18.09.2021].
4. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the dia-betes epidemic. Nature 2001; 414 (6865): 782–7. DOI: 10.1038/414782a. PMID: 11742409.
5. Bhupathiraju SN, Hu FB. Epidemiology of Obesity and Diabetes and Their Car-diovascular Complications. Circ Res 2016; 118 (11): 1723–35. DOI: 10.1161/CIRCRESAHA.115.306825. PMID: 27230638; PMCID: PMC4887150.
6. Ruiz-Canela M, Zazpe I, Shivappa N et al. Dietary inflammatory index and anthropometric measures of obesity in a population sample at high cardio-vascular risk from the PREDIMED (PREvención con DIeta MEDiterránea) trial. Br J Nutr 2015; 113 (6): 984–95. DOI: 10.1017/S0007114514004401. PMID: 25720588; PMCID: PMC4870040.
7. Boden G, Sargrad K, Homko C et al. Effect of a low-carbohydrate diet on ap-petite, blood glucose levels, and insulin resistance in obese patients with type 2 diabetes. Ann Intern Med 2005; 142 (6): 403–11. DOI: 10.7326/0003-4819-142-6-200503150-00006. PMID: 15767618.
8. Johnston CS, Tjonn SL, Swan PD et al. Ketogenic low-carbohydrate diets have no metabolic advantage over nonketogenic low-carbohydrate diets. Am J Clin Nutr 2006; 83 (5): 1055–61. DOI: 10.1093/ajcn/83.5.1055. PMID: 16685046.
9. Hugon P, Dufour JC, Colson P et al. A comprehensive repertoire of prokary-otic species identified in human beings. Lancet Infect Dis 2015; 15 (10): 1211–19. DOI: 10.1016/S1473-3099(15)00293-5. PMID: 26311042.
10. Vergès B, Duvillard L, Lagrost L et al. Changes in lipoprotein kinetics asso-ciated with type 2 diabetes affect the distribution of lipopolysaccharides among lipoproteins. J Clin Endocrinol Metab 2014; 99 (7): E1245–53. DOI: 10.1210/jc.2013-3463. PMID: 24694333.
11. Zhang H, DiBaise JK, Zuccolo A et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci USA 2009; 106: 2365–70. DOI: 10.1073/pnas.0812600106
12. Ceperuelo-Mallafré V, Llauradó G, Keiran N et al. Preoperative Circulating Succinate Levels as a Biomarker for Diabetes Remission After Bariatric Surgery. Diabetes Care 2019; 42 (10): 1956–65.
13. Mikkelsen KH, Knop FK, Frost M et al. Use of antibiotics and risk of type 2 di-abetes: a population-based case-control study. J Clin Endocrinol Metab 2015; 100 (10): 3633–40.
2. Ortega MA, Fraile-Martínez O, Naya I et al. Type 2 Diabetes Mellitus Associ-ated with Obesity (Diabesity). The Central Role of Gut Microbiota and Its Translational Applications. Nutrients 2020; 12 (9): 2749. Published 2020 Sep 9. DOI: 10.3390/nu12092749
3. World Health Organization. Fact sheets. Obesity and overweight. 09.06.2021. https://www.who.int/ru/news-room/fact-sheets/detail/obe-sity-and-overweight. [Access date: 18.09.2021].
4. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the dia-betes epidemic. Nature 2001; 414 (6865): 782–7. DOI: 10.1038/414782a. PMID: 11742409.
5. Bhupathiraju SN, Hu FB. Epidemiology of Obesity and Diabetes and Their Car-diovascular Complications. Circ Res 2016; 118 (11): 1723–35. DOI: 10.1161/CIRCRESAHA.115.306825. PMID: 27230638; PMCID: PMC4887150.
6. Ruiz-Canela M, Zazpe I, Shivappa N et al. Dietary inflammatory index and anthropometric measures of obesity in a population sample at high cardio-vascular risk from the PREDIMED (PREvención con DIeta MEDiterránea) trial. Br J Nutr 2015; 113 (6): 984–95. DOI: 10.1017/S0007114514004401. PMID: 25720588; PMCID: PMC4870040.
7. Boden G, Sargrad K, Homko C et al. Effect of a low-carbohydrate diet on ap-petite, blood glucose levels, and insulin resistance in obese patients with type 2 diabetes. Ann Intern Med 2005; 142 (6): 403–11. DOI: 10.7326/0003-4819-142-6-200503150-00006. PMID: 15767618.
8. Johnston CS, Tjonn SL, Swan PD et al. Ketogenic low-carbohydrate diets have no metabolic advantage over nonketogenic low-carbohydrate diets. Am J Clin Nutr 2006; 83 (5): 1055–61. DOI: 10.1093/ajcn/83.5.1055. PMID: 16685046.
9. Hugon P, Dufour JC, Colson P et al. A comprehensive repertoire of prokary-otic species identified in human beings. Lancet Infect Dis 2015; 15 (10): 1211–19. DOI: 10.1016/S1473-3099(15)00293-5. PMID: 26311042.
10. Vergès B, Duvillard L, Lagrost L et al. Changes in lipoprotein kinetics asso-ciated with type 2 diabetes affect the distribution of lipopolysaccharides among lipoproteins. J Clin Endocrinol Metab 2014; 99 (7): E1245–53. DOI: 10.1210/jc.2013-3463. PMID: 24694333.
11. Zhang H, DiBaise JK, Zuccolo A et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci USA 2009; 106: 2365–70. DOI: 10.1073/pnas.0812600106
12. Ceperuelo-Mallafré V, Llauradó G, Keiran N et al. Preoperative Circulating Succinate Levels as a Biomarker for Diabetes Remission After Bariatric Surgery. Diabetes Care 2019; 42 (10): 1956–65.
13. Mikkelsen KH, Knop FK, Frost M et al. Use of antibiotics and risk of type 2 di-abetes: a population-based case-control study. J Clin Endocrinol Metab 2015; 100 (10): 3633–40.